Molecular Templates, Inc. Made Big Gain
Molecular Templates, Inc. (MTEM:NASDAQ) shot up at $0.54, a gain of 60.3%. On Thu, Dec 05, 2024, MTEM:NASDAQ touched a New 2-Week High of $0.54. The stock got featured on our News Catalysts scanner on Mon, Dec 02, 2024 at 08:32 PM in the 'EARNINGS' category. From Thu, Nov 21, 2024, the stock recorded 33.33% Up Days and 20.00% Green Days
The stock spiked on Thu, Dec 05, 2024 at $0.78 with a volume of 249M+.
About Molecular Templates, Inc. (MTEM:NASDAQ)
Molecular Templates Inc is a clinical-stage biopharmaceutical company. It develops next generation immunotoxins known as Engineered Toxin Bodies for the treatment of individuals living with various cancer.
Top 10 Gainers:
- Oriental Rise Holdings Limited (ORIS:NASDAQ), 599.25%
- Arcadia Biosciences, Inc. (RKDA:NASDAQ), 93.95%
- ArTara Therapeutics, Inc. (TARA:NASDAQ), 70.06%
- PainReform Ltd. (PRFX:NASDAQ), 67.91%
- CalAmp Corp. (CAMP:NASDAQ), 65.99%
- Molecular Templates, Inc. (MTEM:NASDAQ), 60.26%
- Bluejay Diagnostics Inc. (BJDX:NASDAQ), 59.38%
- Cardio Diagnostics Holdings Inc Com (CDIO:NASDAQ), 56.05%
- Foxx Development Holdings Inc. (FOXX:NASDAQ), 54.69%
- SRIVARU Holding Limited (SVMH:NASDAQ), 48.94%